Affluent Medical SA (EPA:AFME)
France · Delayed Price · Currency is EUR 1.970
-0.030 (-1.50%)
At close: Jan 30, 2026
Affluent Medical Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -14.74 | -14.74 | -15.65 | -15.23 | -14.82 | -14.32 |
Depreciation & Amortization | 2.38 | 2.4 | 2.41 | 2.42 | 2.39 | 1.88 |
Other Amortization | - | - | 0.03 | 0.03 | 0.03 | 0.03 |
Loss (Gain) From Sale of Assets | - | - | 0 | 0.02 | -0.02 | - |
Loss (Gain) on Equity Investments | - | - | - | - | 0.01 | 0.4 |
Stock-Based Compensation | 0.62 | 0.78 | 0.73 | 0.15 | 0.04 | 0.96 |
Other Operating Activities | -0.22 | 0.03 | 0.19 | 0.81 | 1.14 | 1.51 |
Change in Accounts Receivable | -0.34 | -1.4 | 0.47 | -1.34 | -1 | 1.73 |
Change in Accounts Payable | 1.05 | 1.36 | 0.35 | 1.23 | -0.56 | -1.35 |
Change in Income Taxes | -0.06 | -0.22 | -0.68 | 0.91 | 0.7 | 0.24 |
Change in Other Net Operating Assets | -3.11 | 0.47 | 0.09 | -0.08 | -0.27 | -0 |
Operating Cash Flow | -14.41 | -11.32 | -12.05 | -11.08 | -12.36 | -8.94 |
Capital Expenditures | -0.19 | -0.15 | -0.17 | -0.15 | -0.33 | -0.3 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.17 | - |
Sale (Purchase) of Intangibles | - | - | -0.01 | - | - | - |
Investment in Securities | -0.02 | -5.33 | - | - | - | - |
Other Investing Activities | 5 | 5 | - | - | - | - |
Investing Cash Flow | 4.8 | -0.48 | -0.18 | -0.15 | -0.16 | -0.3 |
Short-Term Debt Issued | - | - | 0.25 | - | - | - |
Long-Term Debt Issued | - | 0.27 | - | - | 3.32 | 8.9 |
Total Debt Issued | 6.34 | 0.27 | 0.25 | - | 3.32 | 8.9 |
Short-Term Debt Repaid | - | -0.35 | - | -0.03 | - | -0.71 |
Long-Term Debt Repaid | - | -1.3 | -1.42 | -2.83 | -5.45 | -2.17 |
Total Debt Repaid | -1.69 | -1.64 | -1.42 | -2.86 | -5.45 | -2.89 |
Net Debt Issued (Repaid) | 4.65 | -1.37 | -1.17 | -2.86 | -2.12 | 6.01 |
Issuance of Common Stock | 9.29 | 12.72 | 12.55 | 5.74 | 21.43 | 7.46 |
Other Financing Activities | 0.1 | 0.02 | -0.07 | -0.49 | -1.02 | -0.7 |
Financing Cash Flow | 14.04 | 11.37 | 11.32 | 2.4 | 18.28 | 12.76 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | 4.42 | -0.43 | -0.92 | -8.83 | 5.76 | 3.52 |
Free Cash Flow | -14.6 | -11.47 | -12.23 | -11.23 | -12.7 | -9.24 |
Free Cash Flow Margin | -277.27% | -214.41% | -998.77% | -838.46% | -875.12% | -1121.36% |
Free Cash Flow Per Share | -0.37 | -0.32 | -0.42 | -0.59 | -0.75 | -0.69 |
Cash Interest Paid | 0.03 | 0.1 | 0.07 | 0.18 | 0.52 | 0.72 |
Cash Income Tax Paid | 0.04 | 0.06 | 0.06 | 0.03 | 0.03 | 0.02 |
Levered Free Cash Flow | -10.17 | -6.39 | -6.65 | -6.52 | -10.53 | -4.88 |
Unlevered Free Cash Flow | -9.88 | -6.08 | -6.41 | -5.86 | -8.63 | -3.55 |
Change in Working Capital | -2.45 | 0.21 | 0.24 | 0.72 | -1.14 | 0.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.